Swiss National Bank Xenon Pharmaceuticals Inc. Transaction History

Swiss National Bank

$150 Billion
Q3 2024

A detailed history of Swiss National Bank transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Swiss National Bank holds 125,300 shares of XENE stock, worth $4.87 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

125,300

Previous 126,100 0.63%

Holding current value

$4.87 Million

Previous $4.92 Million 0.28%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$36.12 - $43.96 $28,895 - $35,168	-800 Reduced 0.63%	125,300 $4.93 Million
Q2 2024 Aug 08, 2024	BUY	$36.25 - $43.75 $83,375 - $100,625	2,300 Added 1.86%	126,100 $4.92 Million
Q4 2023 Feb 06, 2024	BUY	$28.7 - $46.46 $347,270 - $562,166	12,100 Added 10.83%	123,800 $5.7 Million
Q3 2023 Nov 08, 2023	BUY	$34.16 - $39.73 $64,903 - $75,487	1,900 Added 1.73%	111,700 $3.82 Million
Q2 2023 Aug 09, 2023	BUY	$34.84 - $43.54 $296,140 - $370,090	8,500 Added 8.39%	109,800 $4.23 Million
Q1 2023 May 10, 2023	SELL	$33.46 - $40.35 $381,444 - $459,990	-11,400 Reduced 10.12%	101,300 $3.63 Million
Q4 2022 Feb 08, 2023	BUY	$33.06 - $39.43 $142,158 - $169,549	4,300 Added 3.97%	112,700 $4.44 Million
Q3 2022 Nov 09, 2022	BUY	$30.79 - $39.82 $18,474 - $23,892	600 Added 0.56%	108,400 $3.91 Million
Q2 2022 Aug 09, 2022	BUY	$25.44 - $35.16 $262,032 - $362,147	10,300 Added 10.56%	107,800 $3.28 Million
Q1 2022 May 09, 2022	BUY	$25.09 - $33.13 $253,409 - $334,613	10,100 Added 11.56%	97,500 $2.98 Million
Q4 2021 Feb 08, 2022	BUY	$15.6 - $35.4 $374,400 - $849,600	24,000 Added 37.85%	87,400 $2.73 Million
Q3 2021 Nov 08, 2021	BUY	$14.86 - $19.45 $22,290 - $29,175	1,500 Added 2.42%	63,400 $969,000
Q2 2021 Aug 06, 2021	SELL	$16.81 - $20.0 $35,301 - $42,000	-2,100 Reduced 3.28%	61,900 $1.15 Million
Q1 2021 May 07, 2021	BUY	$13.65 - $21.31 $20,475 - $31,964	1,500 Added 2.4%	64,000 $1.15 Million
Q2 2020 Aug 05, 2020	BUY	$10.21 - $14.9 $638,125 - $931,250	62,500 New	62,500 $784,000

Others Institutions Holding XENE

# of Institutions

212

Shares Held

70.2M

Call Options Held

88.3K

Put Options Held

28.8K

View Full List

About Xenon Pharmaceuticals Inc.

Ticker XENE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,263,500
Market Cap $2.42B
Description
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...

More about XENE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Account

Swiss National Bank Xenon Pharmaceuticals Inc. Transaction History